Anti-ALAD monoclonal antibody

Pre-made anti-ALAD monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ALAD/ALAD products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T20514-Ab-1/ GM-Tg-hg-T20514-Ab-2Anti-Human ALAD monoclonal antibodyHuman
GM-Tg-rg-T20514-Ab-1/ GM-Tg-rg-T20514-Ab-2Anti-Rat ALAD monoclonal antibodyRat
GM-Tg-mg-T20514-Ab-1/ GM-Tg-mg-T20514-Ab-2Anti-Mouse ALAD monoclonal antibodyMouse
GM-Tg-cynog-T20514-Ab-1/ GM-Tg-cynog-T20514-Ab-2Anti-Cynomolgus/ Rhesus macaque ALAD monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T20514-Ab-1/ GM-Tg-felg-T20514-Ab-2Anti-Feline ALAD monoclonal antibodyFeline
GM-Tg-cang-T20514-Ab-1/ GM-Tg-cang-T20514-Ab-2Anti-Canine ALAD monoclonal antibodyCanine
GM-Tg-bovg-T20514-Ab-1/ GM-Tg-bovg-T20514-Ab-2Anti-Bovine ALAD monoclonal antibodyBovine
GM-Tg-equg-T20514-Ab-1/ GM-Tg-equg-T20514-Ab-2Anti-Equine ALAD monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T20514-Ab-1/ GM-Tg-hg-T20514-Ab-2; GM-Tg-rg-T20514-Ab-1/ GM-Tg-rg-T20514-Ab-2;
GM-Tg-mg-T20514-Ab-1/ GM-Tg-mg-T20514-Ab-2; GM-Tg-cynog-T20514-Ab-1/ GM-Tg-cynog-T20514-Ab-2;
GM-Tg-felg-T20514-Ab-1/ GM-Tg-felg-T20514-Ab-2; GM-Tg-cang-T20514-Ab-1/ GM-Tg-cang-T20514-Ab-2;
GM-Tg-bovg-T20514-Ab-1/ GM-Tg-bovg-T20514-Ab-2; GM-Tg-equg-T20514-Ab-1/ GM-Tg-equg-T20514-Ab-2
Products NameAnti-ALAD monoclonal antibody
Formatmab
Target NameALAD
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ALAD monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T20514-Ag-1Recombinant multi-species HEM2/ ALAD/ ALADH protein
    ORF Viral VectorvGMLP000780human ALAD Lentivirus particle
    ORF Viral VectorpGMLP000780human ALAD Lentivirus plasmid
    ORF Viral VectorpGMLPm000512mouse Alad Lentivirus plasmid
    ORF Viral VectorvGMLPm000512mouse Alad Lentivirus particle


    Target information

    Target IDGM-T20514
    Target NameALAD
    Gene ID210,17025,25374,705193,474808,101096680,510679,100052763
    Gene Symbol and SynonymsALAD,ALADH,ALADR,aminolevulinatedelta-dehydratase,Lv,PBGS
    Uniprot AccessionP13716,P06214,Q58DK5
    Uniprot Entry NameHEM2_HUMAN,HEM2_RAT,HEM2_BOVIN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000148218
    Target ClassificationN/A

    The target: ALAD, gene name: ALAD, also named as ALADH, PBGS. The ALAD enzyme is composed of 8 identical subunits and catalyzes the condensation of 2 molecules of delta-aminolevulinate to form porphobilinogen (a precursor of heme, cytochromes and other hemoproteins). ALAD catalyzes the second step in the porphyrin and heme biosynthetic pathway; zinc is essential for enzymatic activity. ALAD enzymatic activity is inhibited by lead and a defect in the ALAD structural gene can cause increased sensitivity to lead poisoning and acute hepatic porphyria. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.